title: [Management of massive hemoptysis].
abstract: Less than 5% of all cases of haemoptysis are considered to be massive, representing a life-threatening condition that warrants urgent investigations and treatment. Efforts should be concentrated on determining the origin of the haemoptysis and the presence of an underlying respiratory pathology, in order to ensure supportive measures and a rapid control of the bleeding. Bronchial artery embolization is considered to be the treatment of choice and thoracic surgery should only be considered in cases of localized lesions with a high risk of re-bleeding, pulmonary artery hemorrhage and failure or contraindications to embolization.
authors.forename: S
authors.initials: S
authors.lastname: Théone
authors.forename: D
authors.initials: D
authors.lastname: Adler
authors.forename: P-A
authors.initials: PA
authors.lastname: Schneider
authors.forename: P M
authors.initials: PM
authors.lastname: Soccal
authors.forename: A B
authors.initials: AB
authors.lastname: Younossian
mesh_terms: D000465:Algorithms; D001981:Bronchial Arteries; D001999:Bronchoscopy; D004621:Embolization, Therapeutic; D004630:Emergencies; D006469:Hemoptysis / Q000628:therapy*; D006801:Humans; D013902:Radiography, Thoracic; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
chemical_list: D014662:Vasoconstrictor Agents